Guangzhou Wondfo Biotech Co.,Ltd financials at a glance

+ Portfolio

The revenue of Guangzhou Wondfo Biotech Co.,Ltd is reported as 2.76491 billion Yuan Renminbi in the fiscal year 2023. The earnings were 1.1 Yuan Renminbi per share in 2023, which was 6.78 lower than 2021. And about -0.10405 billion Yuan Renminbi are reported as free cash flow in the financials of Guangzhou Wondfo Biotech Co.,Ltd 2023. Dividends of 0.4 Yuan Renminbi per share were paid to shareholders of Guangzhou Wondfo Biotech Co.,Ltd stock SZSE:300482 in fiscal 2023.

¥2.76B

Revenue

¥1.10

Earnings Per Share

62.61%

Gross Margin %

¥0.00M

Free Cash Flow

Revenue

2,764.91

Earnings Per Share

1.10

Gross Margin %

62.61

Free Cash Flow

0.00

Financials

Year	Year	TTM	2023	2021	2020	2019	2016	2015
Rev.	Revenue	N/A	¥2.76B	¥3.36B	¥2.81B	¥2.09B	¥547.35M	¥428.78M
GM %	Gross Margin %	55.57%	62.61%	58.46%	69.02%	65.21%	68.49%	66.77%
OM	Operating Margin	12.27%	18.44%	18.88%	29.37%	24.85%	25.01%	25.95%
EPS	Earnings Per Share	¥0.81	¥1.10	¥1.18	¥1.34	¥0.84	¥0.30	¥0.28
Div.	Dividends	N/A	¥0.40	¥0.00	¥0.00	¥0.19	¥0.00	¥0.00
PR %	Payout Ratio %	0	36.36%	0	0	22.62%	0	0
Sha.	Shares	N/AM	455.12M	444.95M	445.34M	445.5M	411.84M	411.84M
OCF	Operating Cash Flow	N/A	¥328.68M	¥664.93M	¥1.06B	¥309.86M	¥112.01M	¥0.00M
FCF	Free Cash Flow	N/A	¥-,104.05M	¥208.44M	¥642.33M	¥130.52M	¥24.04M	¥0.00M
FCFS	Free Cash Flow Per Share	¥0.26	¥-0.23	¥0.47	¥1.46	¥0.38	¥0.08	¥0.37

Guangzhou Wondfo Biotech Co.,Ltd financials at a glance

Financials

Discover